Clinical Trial Update: Kanagawa Combination Anti-hypertensive Therapy (K-CAT) [Phase 4]

View source ↗

Summary

Phase 4 study update on Kanagawa Combination Anti-hypertensive Therapy (K-CAT) for hypertension; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Snippet

Sponsor: Yokohama City University Medical Center | Conditions: Hypertension | Phase 4 | Status: COMPLETED